In this regard, two of these biomarkers, EFTUD2 and PTBP1 correlated with MoCA scores in drug naïve PD patients obtained from the Parkinson’s Progression Markers Initiative (PPMI; Santiago and Potashkin, 2015a). Here, PTBP1 is linked to Parkinson disease.